About Conatus Pharmaceuticals Inc - CNAT
At the moment the company generates 35M USD in revenues.
On its last earning announcement, the company reported a loss of -0.62$ per share.
The book value per share is 0.66$
Conatus Pharmaceuticals Inc - CNAT website
Create a solid portfolio with CNAT
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35M | - | -19M | -53.40% | -18M | -0.62 | - | - | 30M | 0.66 | -36M | - | -36M |